Nadia Waheed
Chief Medical Officer · OCULAR THERAPEUTIX, INC
- 2025
- Jun 5, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nadia Waheed files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Pravin Dugel - $1.94M in OCUL purchases and sales in the last 12 months
- Richard L. Md Lindstrom - $461K in OCUL purchases and sales in the last 12 months
- Namrata Saroj - $278K in OCUL purchases and sales in the last 12 months
- Donald Notman - $216K in OCUL purchases and sales in the last 12 months
- Jeffrey S. Heier - $204K in OCUL purchases and sales in the last 12 months
- Peter Kaiser - $187K in OCUL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nadia Waheed?
Nadia Waheed is a corporate insider, tracked as Chief Medical Officer of OCULAR THERAPEUTIX, INC (OCUL). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Nadia Waheed last file a Form 4?
The most recent primary Form 4 on record is dated 5 June 2026, one of 4 filings going back to 2025.
Has Nadia Waheed been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($221K) across all tracked filings.
